<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>中睿医药评论 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-09T20:30:50+08:00</updated>
  <subtitle>中睿咨询致力于帮助中国本土大中型企业和具备核心资源的中小成长型企业构建企业战略和战术落地高度融合的一体化的体系。推动企业在明确战略方向指引下，实现持续成长！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2 个 1 类新药已报产，荣昌生物正式在港交所上市</title>
    <updated>2020-11-09T17:31:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/cihue88Nz1S9z0gNljuoig</id>
    <link href="https://mp.weixin.qq.com/s/cihue88Nz1S9z0gNljuoig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>成都赜灵生物引进5款创新药，NLRP3抑制剂、RIP1/2抑制剂等值得关注</title>
    <updated>2020-11-09T17:31:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/vSM0nX4LpG_yuvGHp4FaLw</id>
    <link href="https://mp.weixin.qq.com/s/vSM0nX4LpG_yuvGHp4FaLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药：50周年庆！5000亿市值！一大批创新药在路上！</title>
    <updated>2020-11-06T13:23:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/ndoaC1e4nnOmR-v33yxUKw</id>
    <link href="https://mp.weixin.qq.com/s/ndoaC1e4nnOmR-v33yxUKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日，百济神州发布第三季度业绩、业务亮点及预计里程碑事件</title>
    <updated>2020-11-06T13:23:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/HEip1hY3gmfkG8v6mwCduA</id>
    <link href="https://mp.weixin.qq.com/s/HEip1hY3gmfkG8v6mwCduA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日，百济神州引进的抗癌新药迪妥昔单抗上市申请获CDE受理</title>
    <updated>2020-11-04T16:51:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/9sWHrLCbBRiCS1FoTUgaTg</id>
    <link href="https://mp.weixin.qq.com/s/9sWHrLCbBRiCS1FoTUgaTg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球销售额15亿美元，青峰药业3类仿制药「拉考沙胺注射液」首家获批</title>
    <updated>2020-11-04T16:51:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/9HtxrTnUTD3ZaOzO5JK-Vw</id>
    <link href="https://mp.weixin.qq.com/s/9HtxrTnUTD3ZaOzO5JK-Vw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴「注射用艾司奥美拉唑钠」首家过评！30 亿大市场迎来新变数</title>
    <updated>2020-11-02T17:08:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/1AmKAGZFJp4m_3CcIE8JPA</id>
    <link href="https://mp.weixin.qq.com/s/1AmKAGZFJp4m_3CcIE8JPA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴「醋酸加尼瑞克注射液」首家通过一致性评价</title>
    <updated>2020-10-29T17:14:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/f2n3j5I9ivGLIkfes7d84Q</id>
    <link href="https://mp.weixin.qq.com/s/f2n3j5I9ivGLIkfes7d84Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>28 亿重磅品种！「恩曲他滨替诺福韦片」第二家获批</title>
    <updated>2020-10-29T17:14:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/mtCJH4ZtZTZPXU1Ntms44w</id>
    <link href="https://mp.weixin.qq.com/s/mtCJH4ZtZTZPXU1Ntms44w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信迪利单抗三季度销售破 6 亿，信达生物 2020 喜讯不断</title>
    <updated>2020-10-28T17:24:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/-onpdFiSIIV9rTXIx9fzeA</id>
    <link href="https://mp.weixin.qq.com/s/-onpdFiSIIV9rTXIx9fzeA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先声药业登陆港股，近50个在研创新品种蓄势待发</title>
    <updated>2020-10-28T17:24:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/4OBflhbDi41IlMucWZFBTA</id>
    <link href="https://mp.weixin.qq.com/s/4OBflhbDi41IlMucWZFBTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚，信达生物新型LAG-3/PD-L1双抗获批临床！</title>
    <updated>2020-10-26T18:07:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/LneA8yn7WRLL0dHgZIzP2g</id>
    <link href="https://mp.weixin.qq.com/s/LneA8yn7WRLL0dHgZIzP2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚，9 款仿制药通过一致性评价，3 款为首家，3 款为第二家</title>
    <updated>2020-10-26T18:07:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/4cZH2ydZPZhekBCY7M8z1g</id>
    <link href="https://mp.weixin.qq.com/s/4cZH2ydZPZhekBCY7M8z1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞 PD-1 联合阿帕替尼 III 期临床获批，用于肝细胞癌术后辅助治疗</title>
    <updated>2020-10-23T17:47:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/a6Qgfb087_6L2JVbxLfFiA</id>
    <link href="https://mp.weixin.qq.com/s/a6Qgfb087_6L2JVbxLfFiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布：两个高难度注射剂仿制药研究技术指导原则</title>
    <updated>2020-10-23T17:47:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/PjAmZ75gekwZ4S855NoanA</id>
    <link href="https://mp.weixin.qq.com/s/PjAmZ75gekwZ4S855NoanA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>打响价格战！三生国健「益赛普」降价 50%</title>
    <updated>2020-10-22T16:52:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-22:/s/dAe_fzhUN9H4NTW3List2g</id>
    <link href="https://mp.weixin.qq.com/s/dAe_fzhUN9H4NTW3List2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝达药业：盐酸埃克替尼片正式进入CDE优先审评程序</title>
    <updated>2020-10-22T16:52:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-22:/s/T76JsmdBGe-tNSFkuvEe7A</id>
    <link href="https://mp.weixin.qq.com/s/T76JsmdBGe-tNSFkuvEe7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>荣昌生物通过港交所聆讯！2款新药商业化在即</title>
    <updated>2020-10-21T16:44:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-21:/s/4rgexG_-MANo-dmmCGjWow</id>
    <link href="https://mp.weixin.qq.com/s/4rgexG_-MANo-dmmCGjWow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>